Clinical trial
A Randomized, Controlled Comparison of Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter (RAFF)
NCT01891058 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled Comparison of Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter (RAFF)
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 18, 2013
- Completion date
- October 31, 2018
- Enrollment
- 396 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.